- Home
- RNAC vs WLII Comparison
RNAC vs WLII Comparison
Compare RNAC & WLII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RNAC | WLII |
|---|---|---|
| Founded | 2007 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 238.9M | 205.1M |
| IPO Year | 2016 | 2026 |
Fundamental Metrics
Financial Performance| Metric | RNAC | WLII |
|---|---|---|
| Price | $8.95 | $10.26 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $34.00 | N/A |
| AVG Volume (30 Days) | ★ 101.7K | 2.1K |
| Earning Date | 05-11-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,797,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.60 | $10.16 |
| 52 Week High | $11.00 | $10.29 |
Technical Indicators
Market Signals| Indicator | RNAC | WLII |
|---|---|---|
| Relative Strength Index (RSI) | 48.36 | 60.67 |
| Support Level | $8.80 | $10.23 |
| Resistance Level | $9.27 | $10.29 |
| Average True Range (ATR) | 0.69 | 0.02 |
| MACD | -0.12 | -0.00 |
| Stochastic Oscillator | 17.14 | 61.76 |
Price Performance
Historical ComparisonAbout RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases. The company uses technology and a manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.
About WLII Willow Lane Acquisition Corp. II Class A Ordinary Shares
Willow Lane Acquisition Corp II is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.